Refreshing results…
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Download from doi.orgMTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers
Download from doi.orgMissing publications? Search for publications with a matching author name.